iShares MSCI Chile ETF (BATS:ECH – Get Free Report) shares hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $25.52 and last traded at $25.93, with a volume of 774117 shares changing hands. The stock had previously closed at $25.61.
iShares MSCI Chile ETF Stock Performance
The business has a fifty day simple moving average of $26.28 and a 200-day simple moving average of $26.67. The stock has a market capitalization of $565.27 million, a P/E ratio of 4.69 and a beta of 0.85.
Hedge Funds Weigh In On iShares MSCI Chile ETF
Several institutional investors have recently made changes to their positions in ECH. Farther Finance Advisors LLC bought a new stake in iShares MSCI Chile ETF in the 3rd quarter valued at about $27,000. AlphaCentric Advisors LLC bought a new stake in shares of iShares MSCI Chile ETF during the second quarter valued at approximately $37,000. SG Americas Securities LLC bought a new stake in iShares MSCI Chile ETF during the 1st quarter valued at $185,000. Mount Lucas Management LP bought a new position in iShares MSCI Chile ETF in the 2nd quarter valued at about $244,000. Finally, Renaissance Technologies LLC bought a new stake in iShares MSCI Chile ETF during the 2nd quarter worth approximately $264,000.
About iShares MSCI Chile ETF
iShares MSCI Chile Capped ETF, formerly iShares MSCI Chile Capped Investable Market Index Fund (the Fund), is an exchange-traded fund. The Fund seeks to provide investment results that correspond generally to the price and yield performance of the MSCI Chile Investable Market Index (the Index). The Index is a free float-adjusted market capitalization index that is designed to measure broad based equity market performance in Chile.
Further Reading
- Five stocks we like better than iShares MSCI Chile ETF
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Intel: Is Now the Time to Be Brave?Â
- P/E Ratio Calculation: How to Assess Stocks
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Trading Halts Explained
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for iShares MSCI Chile ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares MSCI Chile ETF and related companies with MarketBeat.com's FREE daily email newsletter.